Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized heparin for acute respiratory distress syndrome
IRCT20230724058907N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of heparin in acute respiratory distress syndrome (ARDS), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
heparin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on IRCT20230724058907N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230724058907N1.